Smart Contact Lenses & Glasses

Thank you to everyone who invested in our most recent funding round. If you would like to be notified of future rounds please submit your email in the form below.

The investor brief has been sent to your inbox.
Oops! Something went wrong while submitting the form.

Innovega’s smart contact lenses and glasses enable patients with moderate to severe visual impairments, including the legally blind, restored independence and quality of life based on their new ability to achieve 20/20 vision.

Innovega’s Eyewear System

Patented smart contact lenses and glasses technology
Designed to eliminate eye strain and headaches
Lightweight and stylish
High-efficiency OLED screens
Unobstructed, panoramic field of view
Integrated vision correction
VR/AR/MR configurations
Novel eye tracking

Innovega Opportunity Roadmap

Visually Impaired
  • Hearing Impaired
  • Cognitive / Memory Impaired
  • Public Safety
  • Enterprise / Industrial
  • Surgical Visualization
  • Telemedicine
  • Golf, Cycling, Snow Sports
  • eSports, Video Gaming
  • Social Media Feeds
  • Information
  • Health and Wellness
  • Smartphone Replacement

Innovega's smart contact lenses and glasses provided 9 visually impaired patients with 20/20 vision

HOW INNOVEGA’S TECHNOLOGY WORKS

Innovega is the creator of smart contact lenses and glasses that work together to deliver high-performance augmented and virtual reality (AR/VR) experiences with stylish, discreet eyewear through its eMacula technology. The combination of wearing Innovega's contact lenses and glasses provides the appearance of normal prescription eyewear instead of a bulky, obtrusive headset. Some of the notable features of the system:

  • The combined optical pathways simultaneously bring into focus the real world and the AR/VR digital content presented in the micro-displays of the eMacula glasses.
  • The multi-patented iOptik smart contact lenses are everyday disposable lenses that utilize the vision prescription of the wearer to create a personalized viewing experience, while the eMacula system was engineered to provide users a wide field of view, high resolution, and rich 3D media experience.
  • The iOptik lenses are designed to eliminate eye strain and discomfort by maintaining the focus of the display content regardless of where the wearer is looking in the real world.

Reasons to Invest

Multiple Exits

Pioneers of Smart Contact Lenses and Glasses Innovations

48 Patent Filings

Robust list of 48 U.S. and International patent filings.

Scalable Eyewear

Eyewear to re-define industries including healthcare, enterprise, public safety, defense, sports, education, and gaming.

Smart Contact Lenses

Enable Greater Display Experiences

Market Forecast

$67 Billion by 2024

Final Phase of FDA

Commencing 510(k) and De Novo Trials

Contracts

$6 Million DARPA and Government Contracts

Product Trials

Commercial Product Beta Trials Forecast for Late 2021

$10 Million

Received from Strategic and Other Investors

Industry Leaders Support Technology

Industry leaders leverage their expertise and provide knowledge and support as business advisors.
Casey Tegreene

Advisor and Chief Technology Strategist

One of four Americans to be listed on more patents than Thomas Edision, recently joined the Innovega team, stating:
"I am delighted to join such a well-respected team and offer my skills and experience to commercialize smart contact lenses and glasses for a market of millions." 
Jeff Bradley

Served as Senior Vise President of AT&T, overseeing the company's introduction of smart phones.

"I enjoy working with Innovega's strong management who I believe are leading the evolution of XR (extended reality) technology. I leverage my ecosystem expertise to help the company grow its assets and realize its potential."
Shane Kim

Served as Corporate Vise President of Microsoft's Xbox division and CEO of GameStop

One of four Americans to be listed on more patents than Thomas Edision, recently joined the Innovega team, stating:
"I have long believed in the potential of Innovega's proprietary and unique approach to unlocking the mass market potential of AR and VR. Given my extensive experience in interactive entertainment, I can see how Innovega's technology could enable amazing AR, VR, and fully immersive entertainment experiences via form factors that are far more comfortable and socially desirable than other solutions." 
Casey Tegreene

Advisor and Chief Technology Strategist

One of four Americans to be listed on more patents than Thomas Edision, recently joined the Innovega team, stating:
"I am delighted to join such a well-respected team and offer my skills and experience to commercialize smart contact lenses and glasses for a market of millions." 
Jeff Bradley

Served as Senior Vise President of AT&T, overseeing the company's introduction of smart phones.

"I enjoy working with Innovega's strong management who I believe are leading the evolution of XR (extended reality) technology. I leverage my ecosystem expertise to help the company grow its assets and realize its potential."
Shane Kim

Served as Corporate Vise President of Microsoft's Xbox division and CEO of GameStop

One of four Americans to be listed on more patents than Thomas Edision, recently joined the Innovega team, stating:
"I have long believed in the potential of Innovega's proprietary and unique approach to unlocking the mass market potential of AR and VR. Given my extensive experience in interactive entertainment, I can see how Innovega's technology could enable amazing AR, VR, and fully immersive entertainment experiences via form factors that are far more comfortable and socially desirable than other solutions." 

Independent Testing Confirms 20/20 Vision in Visually Impaired Patients

Innovega's smart contact lenses and glasses provided 9 visually impaired patients with 20/20 vision

In 2019, The Ohio State University tested a group visually impaired including legally blind subjects who wore Innovega's smart contact lenses and glasses and viewed a magnified display of their surroundings. The subjects ranged from age 26-76 with a range of causes of vision loss that included albinism, Stargardt disease, myopic degeneration, histoplasmosis, optic and age-related macular degeneration (AMD).

Distance Acuity
Near Acuity
Reading Speed
Reading Distance
Average Best Spectacle Correction
20/115
N/A
N/A
N/A
Average with Patients' Habitual Aids
20/29
20/125
Normal
7"
Average with Innovega Lenses and Glasses
20/20
20/21
Normal
Normal 16"
Invest Now

Decades of experience in launching, scaling and selling innovative products and the companies that developed them

Management Team

Steve Willey, MASc, MBA

Co-founder, Director, CEO

Former co-founder and president of NASDAQ-listed MicroVision International Inc., founding board member of listed companies Lumera and eDispatch; former CEO of telematics pioneer AirIQ; former innovator in fields of cellular technology, navigation, video gaming, with exits to global OEMs, that included Motorola and others.
Dr. Jerome A. Legerton, OD, MS, MBA

Co-founder, Director, Chief Clinical Officer

Former managing director of the largest multi-specialty optometric practice in California; served as the Director of Clinical Research for Pilkington Barnes Hind and as Vice President, Advanced Technology and Market Development for Paragon Vision Sciences; the co-founder and lead inventor for SynergEyes Inc. and served as SynergEyes Chief Technology Officer and Executive Vice President.
Jay Marsh, MSME

Vice President, Engineering

Former Vice President Engineering, Advanced Projects Research, developing technologies related to laser based and optical diagnostics for combustion research, unsteady combustion propulsion systems, Li-Ion battery energy management and wind tunnel related systems.

Independent Directors

Shane Kim

Video Game and Entertainment Software Industry

Former leader at Microsoft in the Xbox business leading Microsoft Game Studios; publisher of leading industry franchises, Halo and Age of Empires; Interim Chief Executive Officer of GameStop, world’s leading video game and entertainment software retailer.
Jeff Bradley

Smart Device and Network Services Industry

Strategic advisor to Globys Inc.; a Board Member, United Way of King County; former AT&T executive for its smart device portfolio, network services marketing, and 3rd party developer program; ended career with responsibility for AT&T’s west region retail sales and distribution.

Business Advisors

Phil Molyneux

Consumer Electronics Industry

  • CEO, Sony North America
  • President, Dyson Americas
Joe Donahoe

Vision / Medical Technology Industry

  • President, Carl Zeiss Vision
  • President, Carl Zeiss Meditec Americas
Joe Sicari

Contact Lens Industry

  • President and CEO,
    Paragon Vision Sciences,
    acquired by CooperVision
Brian Kelleher

Investment and Medical Technology Industry

  • Managing Partner,Tigris Ventures
  • Co-founder, Chairman,
    Tear Film Innovations,
    acquired by Alcon
Robert Simmonds

Mobile Communications Industry

  • Chairman, Lenbrook Companies
  • Chairman, Clearnet Communications Inc
  • Board Director, Bell Canada
Dan Spira

Healthcare Industry

  • CEO, iNova Pharmaceuticals
  • VP, Bausch Health North America
  • VP, Johnson & Johnson Pacific
Joe Hogan

Mobile Technology Industry

  • Founder and CTO, Openet Telecom Group
  • Architect, Sun Microsystems
Ken Blakeslee

Mobile Technology Industry

  • Chairman, Web Mobility Ventures
  • VP, Nortel Networks
Walter J. Lack

Legal

  • Founder and Managing Partner, Engstrom, Lipscomb & Lack
Avram Miller

Corporate and Business Development

  • Founder, Intel Capital
  • VP, Intel Corporation
Vijay Raghavan

Corporate Finance, Accounting, M&A

  • CFO, AGC Biologics
  • Director Financial Planning,
    Cray Inc

Clinical and Technical Advisors

Joseph T. Barr

OD, MS

Former Global VP for Clinical and Medical Affairs, Bausch & Lomb; Emeritus Professor, The Ohio State University
Richard Lindstrom

MD

Founder and Attending Surgeon Minnesota Eye Consultants; ophthalmology expert in medical devices and corneal and cataract surgery
Mark Bullimore

PhD

Former FDA Ophthalmic Device Panel Member; FDA expert on vision assessment
Jim Schwiegerling

PhD

Professor, University of Arizona, College of Optical Sciences
Steve Schallhorn

MD

Ophthalmology expert in medical devices and corneal and cataract surgery; founded the Department of Defense refractive surgery program; Professor of Ophthalmology at the University of California San Francisco
William Gleason

OD

Founder and CEO, Foresight Regulatory Strategies, Inc; most experienced Contract Research Organization for contact lenses in North America
Richard Lippman

OD

Regulatory Consultant; 10 years head of the Ophthalmic Device Division of the Center for Devices and Radiological Health of the U.S. Food and Drug Administration
Brian Chou

OD

Specialty contact lens expert; fellowship training at Jules Stein Eye Institute, UCLA School of Medicine, in the Cornea and External Disease Division. Advisory board member for the GP Lens Institute

Access the Investor Brief

The investor brief has been sent to your inbox.
Oops! Something went wrong while submitting the form.

Questions about this Investment Opportunity?

For all investor-related questions, please email us or join the discussion on SeedInvest.

Innovega Inc. is offering securities through the use of an Offering Statement that has been qualified by the Securities and Exchange Commission under Tier II of Regulation A. A copy of the Final Offering Circular that forms a part of the Offering Statement may be both here.